Abstract
The presence of a scaffold for cellular spreading and proliferation is a precondition for the development of traction membranes in proliferative vitreoretinopathy (PVR). This study shows the presence of the serum spreading factor, vitronectin, in the extracellular matrix of periretinal membranes removed during vitreoretinal surgery. By means of a double label immunofluorescence protocol, a partial colocalisation of vitronectin with fibronectin at the magnification of light microscopy can be detected. Fibronectin is a high-molecular glycoprotein with multiple biological functions including the mediation of cell attachment and migration. Both proteins share a special cell recognition site which could be a target for experimental pharmacological approaches to PVR. Preliminary studies of vitreous aspirates using electrophoresis and Western blotting indicate that vitronectin may play a more important role in post-traumatic PVR as compared to PVR following rhegmatogenous retinal detachment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Avery RL, Glaser BM. Inhibition of retinal pigment epithelial cell attachment by a synthetic peptide derived from the cell-binding domain of fibronectin. Arch Ophthalmol 1986; 104: 1220–1222.
Barnes D, Sato G. Serum-free cell culture: a unifying approach. Cell 1980; 22: 649–655.
Barnes D, Silnutzer J. Isolation of human serum spreading factor. J Biol Chem 1983; 258: 12548–12552.
Barnes DW, Silnutzer J, See C, Shaffer M. Characterization of human serum spreading factor with monoclonal antibody. Proc Natl Acad Sci USA 1983; 80: 1362–1366.
Boulton M, McKechnie NM, Breda J, Bayly M, Marshall J. The formation of autofluorescent granules in cultured human RPE. Invest Ophthalmol Vis Sci 1989; 30: 82–89.
Campochiaro PA, Jerdan JA, Glaser BM, Cardin A, Michels RG. Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol 1985; 103: 1403–1405.
Görg A, Postel W, Westermaier R, Gianazza E, Righetti PG. Gel gradient electrophoresis, isoelectric focusing and two-dimensional techniques in horizontal, ultrathin polyacrylamide layers. J Biochem Biophys Methods 1980; 3: 273–284.
Hayman EG, Pierschbacher MD, Öhgren Y, Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci USA 1983; 80: 4003–4007.
Hayman EG, Pierschbacher MD, Ruoslahti E. Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol 1987; 100: 1948–1954.
Hebda PA, Alstadt SP, Hileman WT, Eaglstein WH. Support and stimulation of epidermal cell outgrowth from porcine skin explants by platelet factors. Br J Dermatol 1986; 115: 529–541.
Hiscott PS, Grierson I, McLeod D. Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohisto-chemical study. Br J Ophthalmol 1985; 69: 810–823.
Holmes RJ. Preparation from human serum of an α1-protein which induces the immediate growth of unadapted cells in vitro. J Cell Biol 32: 297–308.
Izumi M, Shimo-Oka T, Morishita N, Ii I, Hayashi M. Identification of the collagen binding domain of vitronectin using monoclonal antibodies. Cell Struct Funct 1988; 13: 217–225.
Jenne D, Stanley KK. Molecular cloning of S-protein: a link between complement, coagulation, and cell substrate adhesion. EMBO J 1986; 4: 3153–3157.
Juliano RL. Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochim Biophys Acta 1987; 907: 261–278.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685.
Lane DA, Flynn AM, Pejler G, Lindahl U, Choay J, Preissner K. Structural requirements for the neutralization of heparinlike saccharides by complement S protein/vitronectin. J Biol Chem 1987; 262: 16343–16348.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275.
McGuire EA, Peacock ME, Inborn RC, Siegel NR, Tollefsen DM. Phosphorylation of vitronectin by a protein kinase in human plasma. Identification of a unique phosphorylation site in the heparin-binding domain. J Biol Chem 1988; 263: 1942–1945.
O'Connor CG, Ashman LK. Application of the nitrocellulose transfer technique and alkaline phosphatase conjugated antiimmunoglobulin for determination of the specifity of monoclonal antibodies to protein mixtures. J Immunol Methods 1982; 54: 267–271.
Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984; 309; 30–33.
Preissner KT, Heimburger N, Anders E, Müller-Berghaus G. Physicochemical, immunochemical, and functional comparison of human S-protein and vitronectin. Evidence for the identity of both plasma proteins. Biochem Biophys Res Commun 1986; 134: 951–956.
Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491–497.
Suzuki S, Pierschbacher MD, Hayman EG, Nguyen K, Öhgren Y, Ruoslahti E. Domain structure of vitronectin. J Biol Chem 1984; 259: 15307–15314.
Tomasini BR, Mosher DF. On the identity of vitronectin and S-protein: immunological crossreactivity and functional studies. Blood 1986; 68: 737–742.
Towbin H, Gordon J. Immunoblotting and dot immunobinding - current status and outlook. J Immunol Methods 1984; 72: 313–340.
Weller M, Heimann K, Wiedemann P. Immunochemical studies of epiretinal membranes using APAAP complexes. Evidence for macrophage involvement in traumatic proliferative vitreoretinopathy. Int Ophthalmol 1988a; 11: 181–186.
Weller M, Heimann K, Wiedemann P. Immunochemical analysis of periretinal membranes. Review and outlook. In: Straub W (ed.) Developments in Ophthalmology Vol. 16, 1989, pp. 54–74.
Weller M, Wiedemann P, Heimann K, Zilles K. The significance of fibronectin in vitreoretinal pathology: a critical evaluation. Graefe's Arch Clin Exp Ophthalmol 1988b; 226: 294–298.
Wiedemann P, Weller M. The pathophysiology of proliferative vitreoretinopathy. Acta Ophthalmol 1988; 66: Suppl. 189.
Yamada KM, Kennedy DW. Peptide inhibitors of fibronectin, laminin, and other adhesion molecules: unique and shared features. J Cell Physiol 1987; 130: 21–28.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weller, M., Wiedemann, P., Bresgen, M. et al. Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy. Int Ophthalmol 15, 93–101 (1991). https://doi.org/10.1007/BF00224460
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00224460